Laminar Therapeutics Stock Is Popping Today: What's Going On?

Larimar Therapeutics Inc (NASDAQ:LRMR) shares are jumping on Wednesday after multiple analysts reiterated their bullish outlook.Larimar Therapeutics stock is at critical resistance. What’s behind LRMR new highs?Citigroup's Samantha Semenkow kept her Buy rating and raised her price target from $12 to $14, and Wedbush's Laura Chico reaffirmed her Outperform rating with an $11 target.FDA Grants Breakthrough Designation To Larimar’s NomlabofuspLarimar Stock Soars Year-Over-YearOver the past year, Larimar has se ...